Equity-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Share-Based Payment Arrangement, Option, Activity

The table below presents the activity and other information on the outstanding stock options:


	Stock Options Outstanding	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value





























Outstanding as of December 31, 2025	1,735,338	$	2.80	7.56	$	4,684


Exercised	(43,430)	1.84

Expired	(156,415)	2.09
Outstanding as of June 30, 2026	1,535,493	$	2.86	7.38	$	1,831

Vested and exercisable as of June 30, 2026	1,097,017	$	2.76	6.95	$	1,591

					As of
					June 30, 2026
Unrecognized compensation costs related to the stock options					$	1,295
Weighted average recognition period for unrecognized compensation costs					2.41 years

Schedule of Share-Based Payment Arrangement, Restricted Stock Unit, Activity

The table below presents the activity and other information on the outstanding RSUs:


	RSUs Outstanding	Weighted-Average Grant Date Fair Value Per Share




















Unvested as of December 31, 2025	11,832,102	$	2.73
Granted	6,525,224	3.39
Vested	(3,696,315)	2.68
Forfeited	(675,684)	2.76
Unvested as of June 30, 2026	13,985,327	$	3.04

		As of
		June 30, 2026
Unrecognized compensation costs related to the RSUs		$	40,398
Weighted average recognition period for unrecognized compensation costs		2.81 years

Schedule of Share-Based Payment Arrangement, Performance Shares, Activity

The table below presents the activity and other information on the outstanding PSUs:


	PSUs Outstanding	Weighted-Average Grant Date Fair Value Per Share




















Unvested as of December 31, 2025	2,830,998	$	3.37

Vested	(1,040,410)	3.84
Forfeited	(1,790,588)	3.68
Unvested as of June 30, 2026	—	$	—

Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions

The table below presents the assumptions used to estimate the grant date fair value of the purchase rights under the ESPP:


	June 1, 2026			December 1, 2025

Price of common stock on the grant date	5.34			6.05
Expected term (in years)	0.50			0.50
Expected volatility(1)	110		%	110		%
Risk-free rate of return	3.8		%	3.8		%
Expected annual dividend yield	—		%	—		%

Fair value of the award on the grant date	$	2.44		$	2.76

(1) Expected volatility is based on a combination of implied and historical equity volatility of selected reasonably similar publicly traded companies.

Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount

The table below presents the total equity-based compensation expense recognized for Class B Units, Stock Options, RSUs, PSUs, and ESPP in selling, general and administrative expense, cost of revenues, and research and development for the following periods:


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Equity-based compensation expense in selling, general and administrative	$	2,566	$	2,439	$	4,563	$	6,526
Equity-based compensation expense in cost of revenues	1,577		1,349		2,782		3,885
Equity-based compensation expense in research and development	600		531		821		1,308
Total equity-based compensation expense	$	4,743	$	4,319	$	8,166	$	11,719